After August 17, 2026, Novus Biologicals products and services will no longer be available on this website; you will access all products and services on rndsystems.com. Create your R&D Systems online account today.
FAB1137P) and (B) Mouse Anti-Human Siglec-9 Monoclonal Antibody (Catalog # MAB1139, filled histogram) or isotype control antibody (Catalog # MAB003, open histogram), followed by PerCP-conjugated Anti-Mouse IgG Secondary Antibody (Catalog # F0114)." class="big_lightbox" target="_blank">
1139-SL), immobilized onto a microplate, supports the adhesion of human red blood cells in a dose-dependent manner (orange line). Adhesion elicited by Recombinant Human Siglec-9 Fc Chimera (10 µg/mL) is neutralized (green line) by increasing concentrations of Mouse Anti-Human Siglec-9 Monoclonal Antibody (Catalog # MAB1139). The ND50 is typically 0.015-0.075 µg/mL." class="big_lightbox" target="_blank">
1139-SL) was serially diluted and captured by Mouse Anti-Human Siglec‑9 Monoclonal Antibody (Catalog # MAB1139) coated on a Clear Polystyrene Microplate (Catalog # DY990). Goat Anti-Human Siglec‑9 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF1139) was biotinylated and incubated with the protein captured on the plate. Detection of the standard curve was achieved by incubating Streptavidin-HRP (Catalog # DY998)" class="big_lightbox" target="_blank">
1139-SL) was serially diluted and captured by Mouse Anti-Human Siglec‑9 Monoclonal Antibody (Catalog # MAB1139) coated on a Clear Polystyrene Microplate (Catalog # DY990). Goat Anti-Human Siglec‑9 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF1139) was biotinylated and incubated with the protein captured on the plate. Detection of the standard curve was achieved by incubating Streptavidin-HRP (Catalog # DY998)" class="big_lightbox" target="_blank">
Putative adhesion molecule that mediates sialic-acid dependent binding to cells. Preferentially binds to alpha-2,3- or alpha-2,6-linked sialic acid. The sialic acid recognition site may be masked by cis interactions with sialic acids on the same cell surface
![Flow Cytometry Siglec-9 Antibody (191240) [Unconjugated]](http://images.novusbio.com/images/antibody/Siglec9_MAB1139_Flow_Cytometry_15111.jpg)
![Immunocytochemistry Siglec-9 Antibody [Unconjugated]](http://images.novusbio.com/images/antibody/Siglec9_AF1139_Immunocytochemistry__Immunofluorescence_17406.jpg)
![N/A Siglec-9 [Biotin]](http://images.novusbio.com/fullsize/elisa/DATA_Siglec9_DY1139_ELISA_1582.jpg)
![SEC-MALS Siglec-9 [Unconjugated]](http://images.novusbio.com/fullsize/11242-sl_recombinant-cynomolgus-siglec-9-fc-chimera-protein-cf-sec-mals-288202515518.jpg)
![Neutralization Siglec-9 Antibody (191240) [Unconjugated]](http://images.novusbio.com/images/antibody/Siglec-9_MAB1139_Block_Neutralize_9011.jpg)
![ELISA Siglec-9 Antibody (191240) [Unconjugated]](http://images.novusbio.com/images/mab1139_human-siglec-9-mab-clone-191240-elisa-639201740030074472.jpg)
![ELISA Siglec-9 Antibody [Unconjugated]](http://images.novusbio.com/images/af1139_human-siglec-9-affinity-purified-polyclonal-ab-elisa-639201854773963948.jpg)
![Bioactivity Siglec-9 [Unconjugated]](http://images.novusbio.com/fullsize/11242-sl_recombinant-cynomolgus-siglec-9-fc-chimera-protein-cf-bioactivity-2792022133129.jpg)
![SDS-Page Siglec-9 [Unconjugated]](http://images.novusbio.com/fullsize/11242-sl_recombinant-cynomolgus-siglec-9-fc-chimera-protein-cf-sds-page-28202212554.jpg)
